2016/2930(DEA)

OTC derivatives, central counterparties and trade repositories: risk-mitigation techniques for OTC derivative contracts not cleared by a central counterparty

Basic information

2016/2930(DEA)

DEA - Delegated acts procedure

Supplementing 2010/0250(COD)

Subject

2.50.03 Securities and financial markets, stock exchange, CIUTS, investments
2.50.08 Financial services, financial reporting and auditing
2.50.10 Financial supervision

Status

Procedure completed - delegated act enters into force

Key players

  • European Parliament
    Committee responsible Rapporteur Appointed
    ECON
    Economic and Monetary Affairs

Key events

Date Event Reference Summary
04/10/2016 Non-legislative basic document published C(2016)06329
06/10/2016 Committee referral announced in Parliament
06/10/2016 Initial period for examining delegated act 3.0 month(s)
26/10/2016 Decision by Parliament T8-0410/2016
21/11/2016 Delegated act not objected by Council

Technical information

Procedure Information
Procedure reference 2016/2930(DEA)
Procedure type DEA - Delegated acts procedure
Nature of procedure Examination of delegated act
Supplementing 2010/0250(COD)
Legal basis Rules of Procedure EP 0114-p6
Stage reached in procedure Procedure completed - delegated act enters into force
Committee dossier ECON/8/08064

Documentation gateway

  • Document type Committee Reference Date Summary
    Recommendation for early non-objection of delegated act B8-1124/2016 19/10/2016
    Text adopted by Parliament, single reading T8-0410/2016 26/10/2016
  • Document type Reference Date Summary
    Non-legislative basic document C(2016)06329 04/10/2016
    Document attached to the procedure C(2016)7575 21/11/2016
    Document attached to the procedure C(2016)7577 22/11/2016
    Document attached to the procedure C(2017)1146 17/02/2017
    Document attached to the procedure C(2019)3258 26/04/2019
    Document attached to the procedure C(2019)4993 02/07/2019
    Document attached to the procedure C(2020)0178 13/01/2020